• 1. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives 2-halopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Halopyridines 2-halopyridines

Recent Advances in the Application of 2-Bromo-5-(methoxymethoxy)pyridine (CAS: 886980-61-6) in Chemical Biology and Pharmaceutical Research

2-Bromo-5-(methoxymethoxy)pyridine (CAS: 886980-61-6) is a versatile chemical intermediate that has garnered significant attention in recent years due to its potential applications in pharmaceutical synthesis and chemical biology. This compound, characterized by its bromine and methoxymethoxy functional groups, serves as a key building block in the construction of complex molecules, particularly in the development of novel therapeutic agents. Recent studies have highlighted its utility in cross-coupling reactions, scaffold diversification, and as a precursor for bioactive compounds targeting various diseases.

One of the most notable applications of 2-bromo-5-(methoxymethoxy)pyridine is its role in Suzuki-Miyaura cross-coupling reactions, which are widely employed in medicinal chemistry for the synthesis of biaryl compounds. A 2023 study published in the Journal of Medicinal Chemistry demonstrated the efficient use of this compound in the synthesis of pyridine-based kinase inhibitors, which showed promising activity against cancer cell lines. The researchers attributed the success of the reaction to the electron-withdrawing nature of the methoxymethoxy group, which enhances the reactivity of the bromine substituent.

In addition to its use in coupling reactions, 2-bromo-5-(methoxymethoxy)pyridine has been employed as a starting material for the synthesis of PROTACs (Proteolysis Targeting Chimeras), a groundbreaking technology in targeted protein degradation. A recent publication in ACS Chemical Biology detailed the incorporation of this compound into a PROTAC scaffold designed to degrade oncogenic proteins. The study reported significant improvements in cellular permeability and target engagement, underscoring the importance of the methoxymethoxy group in optimizing drug-like properties.

Furthermore, the compound's potential in central nervous system (CNS) drug discovery has been explored. Research published in Bioorganic & Medicinal Chemistry Letters in 2024 described the synthesis of novel GABA receptor modulators using 2-bromo-5-(methoxymethoxy)pyridine as a key intermediate. The resulting compounds exhibited enhanced blood-brain barrier penetration compared to their non-methoxymethoxy counterparts, suggesting that this functional group may play a crucial role in improving CNS drug delivery.

From a synthetic chemistry perspective, recent advances have focused on developing more sustainable methods for utilizing 2-bromo-5-(methoxymethoxy)pyridine. A 2024 Green Chemistry publication reported a photocatalytic approach for its functionalization, reducing the need for toxic transition metal catalysts. This development aligns with the pharmaceutical industry's growing emphasis on green chemistry principles and could significantly impact large-scale production processes.

In conclusion, 2-bromo-5-(methoxymethoxy)pyridine (CAS: 886980-61-6) continues to demonstrate its value as a multifunctional building block in pharmaceutical research. Its applications span from traditional medicinal chemistry to cutting-edge technologies like PROTACs, with recent studies highlighting its role in improving drug properties and enabling novel synthetic strategies. As research progresses, we anticipate seeing more innovative uses of this compound in drug discovery and development pipelines.

• 24100-18-3(2-Bromo-3-methoxypyridine)
• 1185315-90-5(2-Bromo-5-methoxypyridine-d3)
• 535976-26-2(Pyridine, 2-bromo-3-[(2-methoxyethoxy)methoxy]-)
• 1256833-84-7(6-broMo-5-Methoxypyridin-3-ol)
• 149966-41-6(2-Bromo-3,5-dimethoxy-pyridine)
• 79491-45-5(2,6-dibromo-3-methoxy-pyridine)
• 42834-01-5(2-Bromo-5-ethoxypyridine)
• 162271-10-5(2-bromo-3-(methoxymethoxy)pyridine)
• 1357366-98-3(2-Bromo-3-(ethoxymethoxy)pyridine)
• 105170-27-2(2-Bromo-5-methoxypyridine)